The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
miology and as a member of the Board of Regents of the American College of Physicians. He is now on the Board of Directors for the American College of Epidemiology. He served on both the Medication Use Task Force of the Joint Commission on the Accreditation of Healthcare Organizations and the Drug Utilization Review Advisory Committee on the United States Pharmacopoeia Convention. He has been elected to the Association of American Physicians, the American Epidemiologic Society, the American Society for Clinical Investigation, and the Institute of Medicine.
Hugh H. Tilson M.D., Dr.P.H., is clinical professor of epidemiology and health policy and senior adviser to the dean at the University of North Carolina School of Public Health. Dr. Tilson is a practicing epidemiologist and outcomes researcher, with a career in preventive medicine and public health that spans more than 30 years and that includes service as a director of both state and local health departments and as vice president for worldwide epidemiology, surveillance, and policy research at GlaxoWellcome. He is the author of more than 100 papers in epidemiology, outcomes and policy research, and public health. He is a fellow of the American College of Epidemiology and is former vice-chair of the American Board of Preventive Medicine. Dr. Tilson also served as president of the American College of Preventive Medicine from 1995 to 1997 and was founding co-president of the International Society for Pharmacoepidemiology. He serves as an adviser and consultant in health outcomes, drug safety, and evidence-based health policy to regulatory and government agencies as well as pharmaceutical companies.